课题基金 / 基金详情

2019 Excitatory Synapses and Brain Function Gordon Research Conference and Seminar

2019 Excitatory Synapses and Brain Function Gordon Research Conference and Seminar
2019兴奋性突触与脑功能戈登研究会议暨研讨会
批准号:
9762311
负责人:
KIMBERLY M. HUBER
金额:
$1.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-04-01 至 2020-03-31

项目摘要

项目成果

KIMBERLY M. HUBER的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 该提案要求R13支持长期、备受关注且广受欢迎的Gordon Research 2019年6月9日至14日在新英格兰大学举行的兴奋性突触和脑功能会议(GRC), 比德福德我。在GRC之前,将举行针对毕业生的戈登研究研讨会(GRS 2019年6月8日,学生和博士后研究员在同一地点。突触是我们 对大脑功能和行为的理解。在中枢神经系统中,兴奋性突触代表 通过局部电路进行信息处理和大脑区域之间的通信的主要手段,因此 起调节感觉处理、运动控制、认知和行为的作用。重要的是,突触作为 许多常用药物的作用部位和突触功能障碍导致许多 神经和精神障碍。这些疾病包括精神分裂症、自闭症、抑郁症、毒瘾、 帕金森氏症、阿尔茨海默病、创伤性脑损伤、中风和癫痫。在某些情况下,突触 功能障碍是疾病的原因,而在其他情况下,它代表着一个或多个 潜在的分子缺陷。因此,这些疾病的治疗策略的目标是修改、修复或 维持突触功能。因此,对突触的发育、结构、 健康和疾病大脑中的分子组织、信号功能和可塑性都是必不可少的 减轻人类神经疾病的负担,预测和改善心理健康。这 Conference的独特之处在于它专注于兴奋性突触,大脑中的主要突触类型,以及它的 参与者包括结构生物学家、分子和发育生物学家、细胞 生物学家、生物化学家、生物物理学家、神经生理学家和系统神经学家。这次会议是 旨在将兴奋性突触功能的基本见解与突触功能的损害联系起来 发生在神经系统疾病中,以及导致药物成瘾的适应不良可塑性。目标是 会议的目的是确定和强调对突触功能和功能障碍的基本新见解 从主题方法出发。该计划的设计还突出了尖端方法,并 在健全的基础生物框架内激发新概念、新方法和新技术 神经科学。这次会议将把世界各地的专家科学家聚集在一个有利于 讨论和交流思想。这次会议上的思想交流一直是推动 菲尔德。我们预计2019年关于兴奋性突触和脑功能的GRC将塑造未来的科学方向 并为NINDS的任务以及NIMH、NIDA和NIH等其他NIH研究所提供关键支持 妮娅。
英文摘要
Summary This proposal requests R13 support for a longstanding, well-attended, and well-received Gordon Research Conference (GRC) on Excitatory Synapses and Brain Function on June 9-14, 2019 at University of New England, Biddeford ME. The GRC will be preceded by a Gordon Research Seminar (GRS) targeted towards graduate students and postdoctoral fellows on June 8, 9 2019 at the same location. The synapse is central to our understanding of brain function and behavior. In the central nervous system, excitatory synapses represent the primary means of information processing by local circuits and communication between brain regions and thus serve to mediate sensory processing, motor control, cognition and behavior. Importantly, synapses serve as the site of action for many commonly prescribed medications and synaptic dysfunction contributes to many neurological and psychiatric disorders. These include schizophrenia, autism, depression, drug addiction, Parkinson's disease, Alzheimer's disease, traumatic brain injury, stroke and epilepsy. In some cases, synaptic dysfunction is causal in disease, whereas in other cases it represents the downstream sequelae of one or more underlying molecular defects. Thus, therapeutic strategies for these diseases are targeted to modify, repair or maintain synaptic function. Therefore, a fundamental understanding of synapse development, structure, molecular organization, signaling function, and plasticity in both the healthy and diseased brain is essential to lessening the burden of human neurological disease and predicting and improving mental health. This conference is unique in its focus on excitatory synapses, the major synapse type in the brain, and in its multidisciplinary group of participants including structural biologists, molecular and developmental biologists, cell biologists, biochemists, biophysicists, neurophysiologists and systems neuroscientists. The conference is intended to relate fundamental insights in excitatory synaptic function to the impairments in synaptic function that occur in neurological disease, as well as the maladaptive plasticity that contributes to drug addiction. The goal of the conference is to identify and highlight fundamental new insights into synaptic function and dysfunction from a thematic approach. The program has been designed to also highlight cutting edge approaches and to stimulate new concepts, methods and technologies within a sound biological framework of fundamental neuroscience. The conference will bring together expert scientists worldwide in an environment that is conducive to discussion and exchange of ideas. The exchange of ideas at this conference has been a driving force for the field. We expect the 2019 GRC on Excitatory Synapses and Brain Function will shape future scientific directions and provide critical support for the mission of NINDS as well as other NIH institutes such as NIMH, NIDA and NIA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FMRP regulation of local and long-range neocortical circuits in the mouse: Links with EEG phenotypes
  • 批准号:
    10669036
  • 项目类别:
  • 资助金额:
    $42.21万
  • 财政年份:
    2020
  • 负责人:
    KIMBERLY M. HUBER
  • 依托单位:
FMRP regulation of local and long-range neocortical circuits in the mouse: Links with EEG phenotypes
  • 批准号:
    10453464
  • 项目类别:
  • 资助金额:
    $42.67万
  • 财政年份:
    2020
  • 负责人:
    KIMBERLY M. HUBER
  • 依托单位:
Sex-specific mechanisms of cortical circuit dysfunction in a mouse ASD model
  • 批准号:
    10052919
  • 项目类别:
  • 资助金额:
    $209.63万
  • 财政年份:
    2020
  • 负责人:
    KIMBERLY M. HUBER
  • 依托单位:
FMRP Regulation of Gene Expression
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
  • 批准号:
    82505677
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    吕雨霏
  • 依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
  • 批准号:
    82574874
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2025
  • 负责人:
    刘天华
  • 依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: